SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009178
Filing Date
2024-03-07
Accepted
2024-03-07 12:11:22
Documents
19
Period of Report
2024-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46343
2 ex4-1.htm EX-4.1 80395
3 ex4-2.htm EX-4.2 78872
4 ex10-1.htm EX-10.1 729887
5 ex99-1.htm EX-99.1 14290
6 ex99-1_001.jpg GRAPHIC 3022
  Complete submission text file 0001493152-24-009178.txt   1214611

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgs-20240303.xsd EX-101.SCH 3018
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgs-20240303_lab.xml EX-101.LAB 34240
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgs-20240303_pre.xml EX-101.PRE 22361
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3469
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 24728943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)